Add-on Acquisition • Internet Software and Services

X-Chem Acquires Glamorous AI

On October 28, 2021, X-Chem acquired internet software and services company Glamorous AI

Acquisition Context

This is X-Chem’s 1st transaction in the Internet Software and Services sector.
This is X-Chem’s 1st transaction in the United Kingdom.

Explore All 10210 Add-on Acquisition Internet Software and Services Deals - Search the Database Free

M&A Deal Summary
Date	October 28, 2021
Target	Glamorous AI
Sector	Internet Software and Services
Buyer(s)	X-Chem
Deal Type	Add-on Acquisition

Target Company

Glamorous AI

London, United Kingdom

Glamorous AI is a provider of artificial intelligence (AI) solutions for drug discovery. RosalindAI specializes in solving challenges inherent to sparse and noisy data sets that makes the majority of disease-associated targets intractable by existing computational technologies. Glamorous AI is based in London, England.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

X-Chem

Waltham, Massachusetts, United States

Category	Company
Founded	2009
Sector	Life Science

DESCRIPTION

X-Chem is a biotechnology company that is a provider of DNA-Encoded Library (DEL)-based discovery services. X-Chem was founded in 2009 and is based in Waltham, Massachusetts.

Deal Context for Buyer	#
Overall	4 of 4
Sector: Internet Software and Services	1 of 1
Type: Add-on Acquisition	4 of 4
Country: United Kingdom	1 of 1
Year: 2021	4 of 4

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-10-25	ComInnex Budapest, Hungary ComInnex is a provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery. ComInnex supports early-stage drug discovery through a range of products and services, focusing on the latest technologies and adapting to new and emerging trends. ComInnex was founded in 2006 and is based in Budapest, Hungary.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-10-25

ComInnex

Budapest, Hungary

ComInnex is a provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery. ComInnex supports early-stage drug discovery through a range of products and services, focusing on the latest technologies and adapting to new and emerging trends. ComInnex was founded in 2006 and is based in Budapest, Hungary.

Buy

Explore Related M&A Activity

Internet Software and Services M&A - Add-on Acquisition M&A Deals - United Kingdom M&A - 2021 M&A